B · Normal
[Tianyu Co., Ltd.: The company has six API varieties entering the U.S. market-related drug supply chain through downstream customers] On November 11, Tianyu Co., Ltd. stated on the interactive platform that the company recently accepted an on-site inspection by the U.S. FDA, and the on-site inspection work has ended. At present, the company has six API varieties entering the U.S. market-related drug supply chain through downstream customers.
Comments